Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OPTImal PHARMacological Therapy for Patients With Heart Failure: The OPTIPHARM-HF Registry

NCT06192524 is registered in ClinicalTrials.gov with Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia as lead sponsor.

NCT NCT06192524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06192524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OPTImal PHARMacological Therapy for Patients With Heart Failure: The OPTIPHARM-HF Registry
Lead sponsor
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Phase
Observational
Overall status
Unknown status
Start date
July 18, 2022
Completion date
October 1, 2025
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure